Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson’s disease

Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson’s disease

Epigallocatechin 3-gallate (EGCG), an abundant polyphenolic component derived from green tea extract, possesses versatile bioactivities that can combat many diseases. During the last decade, EGCG was shown to be effective in experimental models of Parkinson’s disease (PD). Several experimental studi...

Full description

Bibliographic Details
Main Authors: Yumin Wang, Shuang Wu, Qiang Li, Weihong Lang, Wenjing Li, Xiaodong Jiang, Zhirong Wan, Jichao Chen, Hongquan Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Pharmacology
Subjects:
Parkinson’s disease
epigallocatechin 3-gallate
oxidative stress
apoptosis
neuroinflammation
α-synuclein
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.977521/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.977521/full

Similar Items